Contrast Agents - News Stories

Contrast-enhanced Ultrasound in Children

Publish Date: 02/04/2017

Pediatric contrast-enhanced ultrasound (CEUS) is a safe procedure and allows for less ionizing radiation and gadolinium contrast administration, according to a study in the American Journal of Roentgenology.

Lantheus Medical Imaging Announces FDA Approval of DEFINITY Label Update

Publish Date: 02/04/2017

The FDA has approved a label update for DEFINITY which removes the contraindication statement related to use in patients with a known or suspected cardiac shunt. A cardiac shunt is a pattern of blood flow in the heart that deviates from the normal path of the circulatory system.

Contraindication Lifted for Ultrasound Contrast Agent

Publish Date: 01/14/2017

The FDA informed New Jersey–based Bracco Diagnostics that it has removed the contraindication for Lumason, an ultrasound contrast agent for use in patients with cardiac shunts.

FDA approves ultrasound contrast agent for pediatric vesicoureteral reflux exam

Publish Date: 01/14/2017

Bracco’s LUMASON is the first ultrasound contrast agent to be approved for use in ultrasonography of the urinary tract (voiding ultrasonography) for the evaluation of suspected or known vesicoureteral reflux in pediatric patients.

FDA approves label changes for GE’s Optison

Publish Date: 10/08/2016

GE Healthcare (NYSE:GE) announced today that the FDA approved label changes for its ultrasound contrast agent Optison, removing contraindications for use in patients with cardiac shunts and for administration by intra-arterial injection.

CEUS Liver and Kidney Tests Produce Big Savings in Testing Time and Cost

Publish Date: 09/10/2016

Contrast-enhanced ultrasound (CEUS) can speed up the diagnosis of patients with liver and kidney diseases, reduce the need for more expensive downstream MR and CT imaging, and reduce overall imaging costs, according to a new study described today at the Advances in Ultrasound Contrast conference.

Taking ultrasound to the molecular level - with gas vesicles

Publish Date: 09/04/2016

The modified gas vesicles (similar to microbubble contrast agents) were shown to give off more distinct ultrasound signals, making them easier to image and they can target specific cell types. In the future, they could be administered to a patient to visualize specific tissues of interest.

Gene therapy via ultrasound could offer new therapeutic tool

Publish Date: 08/27/2016

Combining ultrasound energy and microbubbles to poke holes in cells may prove to be a new tool in the fight against cardiovascular disease and cancer.

Contrast enhanced ultrasound superior to CT for characterizing dynamic features of hepatocellular adenoma

Publish Date: 07/03/2016

Compared with dynamic CT, CEUS was superior at characterizing specific dynamic features. Considering that it is radiation-free, readily availability and easy to use, CEUS is suggested as the first line imaging tool to diagnose HCA.

A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA.

Publish Date: 06/15/2016

This editorial published in the European Journal of Ultrasound in Medicine (Ultraschall in der Medizin) provides a review of the history behind the FDA approval of Lumason for liver imaging and speculates on the role the USA will play in future development of clinical applications of CEUS.

Researchers Seek to Image Gut Bacteria with Sound Waves

Publish Date: 06/11/2016

Certain photosynthetic single-celled organisms develop proteins that form gas-filled structures. The researchers plan to genetically engineer gut bacteria to produce these proteins, essentially causing the bacteria to produce ultrasound contrast agents within the cell.

Directing Chemotherapy Microbubbles To Tumors Using Magnets

Publish Date: 04/23/2016

Scientists have created microbubbles coated with cancer drug particles and iron oxide nanoparticles, and then used magnets to direct these bubbles to gather around a specific tumour.

Physician Group Applauds FDA Approval of New Liver Imaging Agent in the US

Publish Date: 04/10/2016

The International Contrast Ultrasound Society (ICUS), an international physician group commended the U.S. Food and Drug Administration (FDA) on its historic decision to allow the use of Lumason®, an ultrasound contrast agent, for diagnostic imaging of the liver in adults and children.

FDA APPROVES ULTRASOUND CONTRAST FOR THE LIVER

Publish Date: 04/09/2016

Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., announced today that LUMASON is now approved for use in ultrasonography of the liver for characterization of focal liver lesions in adult and pediatric patients.

Ultrasound-activated microbubbles restore blood flow to heart muscle during heart attack

Publish Date: 02/14/2016

NIBIB-funded researchers used ultrasound-activated microbubbles to improve preservation of heart muscle and function in a pig heart attack model. Based on this success, the method is now in phase I human clinical trials.

Tiny drug-laden 'popping bubbles' lead triple attack treatment for liver cancer

Publish Date: 12/13/2015

A 'triple attack' technique combining chemotherapy, thermal ablation, and hyperthermia provided a highly targeted, yet minimally invasive approach.

Ultrasound captures rat brain in microscopic 3D

Publish Date: 11/28/2015

Scientists in France have developed an ultrasound technique based on microbubble contrast that can rapidly build up a 3D view of a network of blood vessels, in microscopic detail.

Ultrasound-mediated oncolytic virus delivery and uptake review

Publish Date: 11/28/2015

Oncolytic viruses can selectively replicate within and destroy a cancer cell, thus making them a powerful therapeutic in treating late-stage or metastatic cancer. This article reviews current state of the art in delivery via microbubbles and ultrasound.

Pilot Study Shows Positive Results for Treatment of Pancreatic Cancer

Publish Date: 09/19/2015

Ultrasound microbubbles can improve tumor absorption of cancer drugs

CEUS Shows Effectiveness of Cancer Therapy in Children

Publish Date: 09/19/2015

A new study shows that contrast-enhanced ultrasound (CEUS) imaging can help predict whether children with cancer will respond favorably to certain cancer drugs that target and destroy tumor blood vessels, according to physicians at St. Jude Children's Research Hospital in Memphis.

Non-Invasive Breast and Ovarian Cancer Screening Study Released

Publish Date: 09/13/2015

The study found that ultrasound contrast allows visualization of KDR (kinase insert domain receptor), a protein associated with certain diseases including cancer.

NIH Awards $1.26M for development of acoustic angiography for cancer research

Publish Date: 08/22/2015

The research project is centered on a novel approach to cancer detection and diagnosis that is based on using acoustic angiography to measure small changes in the microvessels that feed tumors. Acoustic angiography is a contrast-enhanced ultrasound imaging technique.

Copper oxide nanoparticles as contrast agents for MRI and ultrasound dual-modality imaging

Publish Date: 07/12/2015

In this study 7 nm copper oxide nanoparticles (CuO NPs) were tested in vitro and in phantoms as a contrast agent for both MRI and through-transmission ultrasound. The particles resulted in a substantial increase in the contrast-to-noise ratio for both modalities.

On-Demand Delivery of Drugs from Nanoparticles Using Ultrasound

Publish Date: 06/21/2015

The technique involves "a hydrogel made of seaweed-derived alginate that contains gold nanoparticles for the delivery of BMP-2, a clinically used drug known to enhance fracture healing when introduced in a controlled manner".

Bubble delivery can rescue failing drug candidates, says Oxford team

Publish Date: 06/06/2015

"The bubble consists of a shell of phospholipids surrounding a gas core made of fluorocarbons..."

Imaging Technique Identifies Early Metastasis in Lymph Nodes

Publish Date: 05/30/2015

The technique uses an imaging approach known as ultrasound-guided photoacoustics combined with nanosensors (gold nanoparticles and an antibody to the epidermal growth factor receptor (EGFR). Early results in mice showed high sensitivity for small metastases in lymph nodes.

Ultrasound-activated bubbles could help make cancer drugs more effective and less nasty

Publish Date: 05/23/2015

"...one of the most versatile means of triggering drug release is by firing a beam of ultrasonic vibrations at the particles. Widely used as an imaging method, ultrasound can be used from outside the body and, unlike light or heat, can be tightly focused to produce highly localised effects."

Measuring reduction in tumor growth with Contrast-enhanced ultrasound (CEUS)

Publish Date: 05/08/2015

CEUS using the “flash replenishment”(FR) method appears to provide a useful assessment of the anti-angiogenic and invasion-inhibiting effects of a triple combination therapy.

Ultrasound with contrast for pediatrics with abdominal trauma superior to CT

Publish Date: 05/08/2015

Results from a recent British study indicate that children who suffer from blunt abdominal injury can effectively be diagnosed and managed with contrast enhanced ultrasound (CEUS).

Gene delivery to the spinal cord using MRI-guided focused ultrasound

Publish Date: 04/25/2015

Non-invasive gene delivery across the blood–spinal cord barrier (BSCB) remains a challenge for treatment of spinal cord injury and disease.

Researchers convert microbubbles to even smaller nanobubbles using ultrasound

Publish Date: 04/04/2015

A team of researchers at the University of Toronto is developing a new form of microbubble delivery. The Toronto team is deploying ultrasound to implode the bubbles into several smaller nanobubbles that can cross biological barriers due to their size and release the payloads within the target area.

Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy

Publish Date: 03/21/2015

The purpose of this study was to elucidate the possibility of combining FUS-induced BBB opening with IL-12 delivery to enhance the anticancer immunological response for glioma treatment.

Modest growth seen for U.S. contrast agent and radiopharmaceutical market

Publish Date: 01/04/2015

The U.S. market for contrast agents and radiopharmaceuticals will grow slightly by 2023, according to a recent Decisions Resources Group report. A number of factors are impacting the market including health care reform, the call for lower radiation dose and reimbursement.

Contrast enhanced ultrasound expands at Point of Care

Publish Date: 11/08/2014

Once considered an add-on examination, contrast enhanced ultrasound (CEUS) at point of care by clinicians expands diagnostic capabilities and is leading to new insights.